Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical Drug Investigation|March 23, 2013
Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjectsArne Ring, Karin Rathgen, Joachim Stangier, et al.
Clinical Therapeutics|August 2, 2011
A randomized, open-label, crossover study evaluating the effect of food on the relative bioavailability of linagliptin in healthy subjectsUlrike Graefe-Mody, Thomas Giessmann, Arne Ring, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 18, 2012
Pharmacokinetics of single and multiple oral doses of 5 mg linagliptin in healthy Chinese volunteersChristian Friedrich, Xiaojin Shi, Peter Zeng, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2008
Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteersFenglei Huang, Michael Koenen-Bergmann, Thomas R Macgregor, et al.
Drug Metabolism and Pharmacokinetics|November 19, 2010
Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjectsUlrike Graefe-Mody, Peter Rose, Arne Ring, et al.
British Journal of Clinical Pharmacology|February 11, 2011
The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic dosesArne Ring, Andreas Port, E Ulrike Graefe-Mody, et al.
Clinical Drug Investigation|July 1, 2011
Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose studyChristian Friedrich, Andreas Port, Arne Ring, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trialsKatrin Metzmann, David Schnell, Arvid Jungnik, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Pharmacokinetics of linagliptin in subjects with hepatic impairmentUlrike Graefe-Mody, Peter Rose, Silke Retlich, et al.
Trials|March 20, 2014
Evaluation of a tailored intervention to improve management of overweight and obesity in primary care: study protocol of a cluster randomised controlled trialJane Krause, Shona Agarwal, Danielle H Bodicoat, et al.
Pageof 4